Design, evaluation and pharmacokinetic study of mucoadhesive buccal tablets of nicotine for smoking cessation

Shaila Lewis, G. Subramanian, S. Pandey, N. Udupa

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Mucoadhesive tablets for buccal administration of nicotine were prepared as an alternative to the available nicotine dosage forms. Three types of tablets were developed each containing two mucoadhesive components (HPMC, K4M and sodium alginate), (HPMC, K4M and carbopol) (Chitosan and sodium alginate). For each of these types, batches were produced changing the quantity of polymers resulting in nine different formulations. The tablets were evaluated for release pattern, and mucoadhesive performance. Pharmacokinetic studies were conducted in smokers. A peak plasma concentration of 16.78±2.27 ng was obtained in two hours, which suggests potential clinical utility in nicotine replacement therapy.

Original languageEnglish
Pages (from-to)829-831
Number of pages3
JournalIndian Journal of Pharmaceutical Sciences
Volume68
Issue number6
Publication statusPublished - 01-02-2006

Fingerprint

Cheek
Smoking Cessation
Nicotine
Tablets
Pharmacokinetics
Buccal Administration
Dosage Forms
Chitosan
Polymers
alginic acid
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{6e5b7414c0404713998e17effeeab3a1,
title = "Design, evaluation and pharmacokinetic study of mucoadhesive buccal tablets of nicotine for smoking cessation",
abstract = "Mucoadhesive tablets for buccal administration of nicotine were prepared as an alternative to the available nicotine dosage forms. Three types of tablets were developed each containing two mucoadhesive components (HPMC, K4M and sodium alginate), (HPMC, K4M and carbopol) (Chitosan and sodium alginate). For each of these types, batches were produced changing the quantity of polymers resulting in nine different formulations. The tablets were evaluated for release pattern, and mucoadhesive performance. Pharmacokinetic studies were conducted in smokers. A peak plasma concentration of 16.78±2.27 ng was obtained in two hours, which suggests potential clinical utility in nicotine replacement therapy.",
author = "Shaila Lewis and G. Subramanian and S. Pandey and N. Udupa",
year = "2006",
month = "2",
day = "1",
language = "English",
volume = "68",
pages = "829--831",
journal = "Indian Journal of Pharmaceutical Sciences",
issn = "0250-474X",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "6",

}

Design, evaluation and pharmacokinetic study of mucoadhesive buccal tablets of nicotine for smoking cessation. / Lewis, Shaila; Subramanian, G.; Pandey, S.; Udupa, N.

In: Indian Journal of Pharmaceutical Sciences, Vol. 68, No. 6, 01.02.2006, p. 829-831.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Design, evaluation and pharmacokinetic study of mucoadhesive buccal tablets of nicotine for smoking cessation

AU - Lewis, Shaila

AU - Subramanian, G.

AU - Pandey, S.

AU - Udupa, N.

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Mucoadhesive tablets for buccal administration of nicotine were prepared as an alternative to the available nicotine dosage forms. Three types of tablets were developed each containing two mucoadhesive components (HPMC, K4M and sodium alginate), (HPMC, K4M and carbopol) (Chitosan and sodium alginate). For each of these types, batches were produced changing the quantity of polymers resulting in nine different formulations. The tablets were evaluated for release pattern, and mucoadhesive performance. Pharmacokinetic studies were conducted in smokers. A peak plasma concentration of 16.78±2.27 ng was obtained in two hours, which suggests potential clinical utility in nicotine replacement therapy.

AB - Mucoadhesive tablets for buccal administration of nicotine were prepared as an alternative to the available nicotine dosage forms. Three types of tablets were developed each containing two mucoadhesive components (HPMC, K4M and sodium alginate), (HPMC, K4M and carbopol) (Chitosan and sodium alginate). For each of these types, batches were produced changing the quantity of polymers resulting in nine different formulations. The tablets were evaluated for release pattern, and mucoadhesive performance. Pharmacokinetic studies were conducted in smokers. A peak plasma concentration of 16.78±2.27 ng was obtained in two hours, which suggests potential clinical utility in nicotine replacement therapy.

UR - http://www.scopus.com/inward/record.url?scp=33947416536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947416536&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 829

EP - 831

JO - Indian Journal of Pharmaceutical Sciences

JF - Indian Journal of Pharmaceutical Sciences

SN - 0250-474X

IS - 6

ER -